Clinical and molecular characterization of early-onset colorectal cancer.

Alexandra N. Willauer , Yusha Liu , Allan A. L. Pereira , Michael Lam
Cancer 125 ( 12) 2002 -2010

182
2019
Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives.

Daniel M. Girardi , Jana Priscila M. Pacífico , Fernanda P. L. Guedes de Amorim , Gustavo dos Santos Fernandes
Pharmaceuticals, policy and law 14 ( 1) 28

13
2020
Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis

Karla T Souza , Allan AL Pereira , Raphael L Araujo , Suilane Coelho Ribeiro Oliveira
Ecancermedicalscience 10 699 -699

10
2016
Systemic therapy for advanced hepatocellular carcinoma: current stand and perspectives

Daniel M Girardi , Lara P Sousa , Thiago A Miranda , Fernanda NC Haum
Cancers 15 ( 6) 1680 -1680

12
2023
Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?

Thiago A Miranda , Daniel M Girardi , Allan AL Pereira
Chinese Clinical Oncology cco -23

2024
Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer

Florinda A Santos , Rui Manuel Reis , Lucas C Barroti , Allan AL Pereira
Journal of Gastrointestinal Cancer 1 -11

2023
Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer

Florinda A Santos , Rui Manuel Reis , Lucas C Barroti , Allan AL Pereira
Journal of Gastrointestinal Cancer 55 ( 1) 344 -354

2024
Partial Response to Dual BRAF and MEK Inhibition in a Patient with BRAF-Mutant Pancreatic Acinar Cell Carcinoma Refractory to Chemotherapy: A Case Report and Review of the Literature

Adriana PC Barrichello , Allan AL Pereira , Maria Dirlei FS Begnami , Marcus Vinicius Grigolon
Clinical Oncology: Case Reports 4 ( 7) 1 -4

2
2021
Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.

Irene S. Yu , Allan A.L. Pereira , Michael Lee , Kritti Korphaisarn
Oncologist 25 ( 3) 229 -234

2
2020
Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes

Kenna Shaw , Russell Broaddus , Mark J. Routbort , Yusha Liu
Clinical Cancer Research 24 ( 5) 1062 -1072

237
2017
Association between KRAS mutation and lung metastasis in advanced colorectal cancer.

A A L Pereira , J F M Rego , V Morris , M J Overman
British Journal of Cancer 112 ( 3) 424 -428

51
2015
EP08. 02-059 EGFR Tyrosine Kinase Inhibitors and Combination Strategies in First-line Treatment of Advanced NSCLC: A Network Meta-analysis

G de Castro , GT Stock , G Harada , AAL Pereira
Journal of Thoracic Oncology 17 ( 9) S426 -S427

2022
Genomic landscape of cell-free DNA in patients with colorectal cancer. Cancer Discov. 2018; 8: 164–173. doi: 10.1158/2159-8290

JH Strickler , JM Loree , LG Ahronian , AR Parikh
CD-17-1009.[Europe PMC free article][Abstract][CrossRef][Google Scholar]

47
Uso de sorafenibe em pacientes com carcinoma hepatocelular (CHC) Child-Pugh B: análise retrospectiva de onze pacientes

RR Munhoz , JFM Rêgo , MI Braghiroli , AAL Pereira
Revista Brasileira de Oncologia Clínica 7 ( 25) 140 -140

2011
Does Endocrine Therapy for DCIS Patients Treated with Breast-Conserving Surgery Followed by Postoperative Radiation Therapy is Needed? A Brazilian Retrospective Cohort Study

CFPM de Sousa , AAL Pereira , AG Gouveia , SA Hanna
International Journal of Radiation Oncology* Biology* Physics 117 ( 2) e173 -e173

2023
Brazilian Pediatric Patients with Gliomas: Treatment Characteristics and Survival Outcomes

MTM Starling , AAL Pereira , CFPM de Sousa , F Restini
International Journal of Radiation Oncology* Biology* Physics 117 ( 2) e531 -e532

2023